Detalles de la búsqueda
1.
hacksig: a unified and tidy R framework to easily compute gene expression signature scores.
Bioinformatics
; 38(10): 2940-2942, 2022 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35561166
2.
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities.
Transl Res
; 265: 1-16, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37949350
3.
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
J Immunother Cancer
; 12(1)2024 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38290766
4.
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.
Biomark Res
; 11(1): 69, 2023 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37455307
5.
Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors.
Front Endocrinol (Lausanne)
; 14: 1267499, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37867524
6.
Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples.
Cancers (Basel)
; 14(8)2022 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35454858
7.
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.
Cells
; 11(19)2022 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36231138
8.
Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.
Oral Oncol
; 126: 105756, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121395
Resultados
1 -
8
de 8
1
Próxima >
>>